{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:49:53Z","timestamp":1773078593341,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,11,30]],"date-time":"2007-11-30T00:00:00Z","timestamp":1196380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s00467-007-0636-6","type":"journal-article","created":{"date-parts":[[2007,11,29]],"date-time":"2007-11-29T14:23:55Z","timestamp":1196346235000},"page":"221-231","source":"Crossref","is-referenced-by-count":22,"title":["Role of the renin angiotensin system in TNF-\u03b1 and Shiga-toxin-induced tissue factor expression"],"prefix":"10.1007","volume":"23","author":[{"given":"Eirini","family":"Nestoridi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafail I.","family":"Kushak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Tsukurov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric F.","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie R.","family":"Ingelfinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,11,30]]},"reference":[{"key":"636_CR1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","volume":"86","author":"M Paul","year":"2006","unstructured":"Paul M, Poyan Mehr A, Kreutz R (2006) Physiology of local renin-angiotensin systems. Physiol Rev 86:747\u2013803","journal-title":"Physiol Rev"},{"key":"636_CR2","first-page":"419","volume":"45","author":"NJ Brown","year":"2000","unstructured":"Brown NJ, Vaughan DE (2000) Prothrombotic effects of angiotensin. Adv Intern Med 45:419\u2013429","journal-title":"Adv Intern Med"},{"key":"636_CR3","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1046\/j.1523-1755.63.s84.12.x","volume":"84","author":"J Galle","year":"2003","unstructured":"Galle J, Quaschning T, Seibold S, Wanner C (2003) Endothelial dysfunction and inflammation: what is the link? Kidney Int Suppl 84:S45\u2013S49","journal-title":"Kidney Int Suppl"},{"key":"636_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0049-3848(95)00209-X","volume":"81","author":"E Camerer","year":"1996","unstructured":"Camerer E, Kolsto AB, Prydz H (1996) Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 81:1\u201341","journal-title":"Thromb Res"},{"key":"636_CR5","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1172\/JCI110945","volume":"71","author":"M Colucci","year":"1983","unstructured":"Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB, Semeraro N (1983) Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 71:1893\u20131896","journal-title":"J Clin Invest"},{"key":"636_CR6","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1538-7836.2007.02435.x","volume":"5","author":"DM Monroe","year":"2007","unstructured":"Monroe DM, Key NS (2007) The tissue factor-factor VIIa complex: procoagulant activity, regulation, and multitasking. J Thromb Haemost 5:1097\u20131105","journal-title":"J Thromb Haemost"},{"key":"636_CR7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1172\/JCI116234","volume":"91","author":"MB Taubman","year":"1993","unstructured":"Taubman MB, Marmur JD, Rosenfield CL, Guha A, Nichtberger S, Nemerson Y (1993) Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation. J Clin Invest 91:547\u2013552","journal-title":"J Clin Invest"},{"key":"636_CR8","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1055\/s-0038-1656136","volume":"77","author":"H Nishimura","year":"1997","unstructured":"Nishimura H, Tsuji H, Masuda H, Nakagawa K, Nakahara Y, Kitamura H, Kasahara T, Sugano T, Yoshizumi M, Sawada S, Nakagawa M (1997) Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells. Thromb Haemost 77:1189\u20131195","journal-title":"Thromb Haemost"},{"key":"636_CR9","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1523-1755.2001.060003831.x","volume":"60","author":"P Ruggenenti","year":"2001","unstructured":"Ruggenenti P, Noris M, Remuzzi G (2001) Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 60:831\u2013846","journal-title":"Kidney Int"},{"key":"636_CR10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00467-001-0783-0","volume":"17","author":"SP Andreoli","year":"2002","unstructured":"Andreoli SP, Trachtman H, Acheson DW Siegler RL, Obrig TG (2002) Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy. Pediatr Nephrol 17:293\u2013298","journal-title":"Pediatr Nephrol"},{"key":"636_CR11","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s004670100660","volume":"16","author":"PE Ray","year":"2001","unstructured":"Ray PE, Liu XH (2001) Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome. Pediatr Nephrol 16:823\u2013839","journal-title":"Pediatr Nephrol"},{"key":"636_CR12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1203\/00006450-200108000-00002","volume":"50","author":"F Proulx","year":"2001","unstructured":"Proulx F, Seidman EG, Karpman D (2001) Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr Res 50:163\u2013171","journal-title":"Pediatr Res"},{"key":"636_CR13","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1538-7836.2005.01205.x","volume":"3","author":"E Nestoridi","year":"2005","unstructured":"Nestoridi E, Tsukurov O, Kushak RI, Ingelfinger JR, Grabowski EF (2005) Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome. J Thromb Haemost 3:752\u2013762","journal-title":"J Thromb Haemost"},{"key":"636_CR14","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1172\/JCI114846","volume":"86","author":"MG Seikaly","year":"1990","unstructured":"Seikaly MG, Arant BS, Seney FD (1990) Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 86:1352\u20131357","journal-title":"J Clin Invest"},{"key":"636_CR15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/1096-8652(200102)66:2<105::AID-AJH1025>3.0.CO;2-1","volume":"66","author":"H Yagi","year":"2001","unstructured":"Yagi H, Narita N, Matsumoto M, Sakurai Y, Ikari H, Yoshioka A, Kita E, Ikeda Y, Titani K, Fujimura Y (2001) Enhanced low shear stress induced platelet aggregation by Shiga-like toxin 1 purified from Escherichia coli O157. Am J Hematol 66:105\u2013115","journal-title":"Am J Hematol"},{"key":"636_CR16","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1182\/blood.V81.12.3265.3265","volume":"81","author":"EF Grabowski","year":"1993","unstructured":"Grabowski EF, Zuckerman DB, Nemerson Y (1993) The functional expression of tissue factor by fibroblasts and endothelial cells under flow conditions. Blood 81:3265\u20133270","journal-title":"Blood"},{"key":"636_CR17","first-page":"1087","volume":"134","author":"TA Drake","year":"1989","unstructured":"Drake TA, Morrissey JH, Edgington TS (1989) Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 134:1087\u20131097","journal-title":"Am J Pathol"},{"key":"636_CR18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0304-3940(02)01423-4","volume":"339","author":"C Ramakers","year":"2003","unstructured":"Ramakers C, Ruijter JM, Deprez RH, Moorman AF (2003) Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 339:62\u201366","journal-title":"Neurosci Lett"},{"key":"636_CR19","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45","journal-title":"Nucleic Acids Res"},{"key":"636_CR20","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1124\/jpet.300.3.729","volume":"300","author":"RJ Shebuski","year":"2002","unstructured":"Shebuski RJ, Kilgore KS (2002) Role of inflammatory mediators in thrombogenesis. Pharmacol Exp Ther 300:729\u2013735","journal-title":"Pharmacol Exp Ther"},{"key":"636_CR21","unstructured":"Di Santo A, Napoleone E, Donati MB, Lorenzet R (2001) Angiotensin II upregulates tissue factor expression by human monocytes. Thromb Haemost SV: OC215"},{"key":"636_CR22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.thromres.2005.04.033","volume":"117","author":"M He","year":"2006","unstructured":"He M, He X, Xie Q, Chen F, He S (2006) Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes. Thromb Res 117:579\u2013590","journal-title":"Thromb Res"},{"key":"636_CR23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa011033","volume":"346","author":"WL Chandler","year":"2002","unstructured":"Chandler WL, Jelacic S, Boster DR, Ciol MA, Williams GD, Watkins SL, Igarashi T, Tarr PI (2002) Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome. N Engl J Med 346:23\u201332","journal-title":"N Engl J Med"},{"key":"636_CR24","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1046\/j.1523-1755.1998.00103.x","volume":"54","author":"C Geet Van","year":"1998","unstructured":"Van Geet C, Proesmans W, Arnout J, Vermylen J, Declerck PJ (1998) Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome. Kidney Int 54:1324\u20131330","journal-title":"Kidney Int"},{"key":"636_CR25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s004670050644","volume":"13","author":"CH Nevard","year":"1999","unstructured":"Nevard CH, Blann AD, Jurd KM, Haycock GB, Hunt BJ (1999) Markers of endothelial cell activation and injury in childhood haemolytic uraemic syndrome. Pediatr Nephrol 13:487\u2013492","journal-title":"Pediatr Nephrol"},{"key":"636_CR26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2261-2-3","volume":"2","author":"J Theuer","year":"2002","unstructured":"Theuer J, Dechend R, Muller DN, Park JK, Fiebeler A, Barta P, Ganten D, Haller H, Dietz R, Luft FC (2002) Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats. BMC Cardiovasc Disord 2:3","journal-title":"BMC Cardiovasc Disord"},{"key":"636_CR27","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1161\/01.CIR.101.20.2382","volume":"101","author":"R Dechend","year":"2000","unstructured":"Dechend R, Homuth V, Wallukat G Kreuzer J, Park JK, Theuer J, Juepner A, Gulba DC, Mackman N, Haller H, Luft FC (2000) AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation 101:2382\u20132387","journal-title":"Circulation"},{"key":"636_CR28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/1389200023337964","volume":"3","author":"M Lassila","year":"2002","unstructured":"Lassila M (2002) Interaction of cyclosporine A and the renin-angiotensin system; new perspectives. Curr Drug Metab 3:61\u201371","journal-title":"Curr Drug Metab"},{"key":"636_CR29","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/ki.1993.90","volume":"43","author":"A Tufro-McReddie","year":"1993","unstructured":"Tufro-McReddie A, Gomez RA, Norling LL, Omar AA, Moore LC, Kaskel FJ (1993) Effect of CsA on the expression of renin and angiotensin type 1 receptor genes in the rat kidney. Kidney Int 43:615\u2013622","journal-title":"Kidney Int"},{"key":"636_CR30","first-page":"211","volume":"3","author":"B Grunfeld","year":"1982","unstructured":"Grunfeld B, Gimenez M, Liapchuc S, Mendilaharzu J, Gianantonio C (1982) Systemic hypertension and plasma renin activity in children with the hemolytic-uremic syndrome. Int J Pediatr Nephrol 3:211\u2013214","journal-title":"Int J Pediatr Nephrol"},{"key":"636_CR31","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/BF00856527","volume":"8","author":"W Proesmans","year":"1994","unstructured":"Proesmans W, VanCauter A, Thijs L, Lijnen P (1994) Plasma renin activity in haemolytic uraemic syndrome. Pediatr Nephrol 8:444\u2013446","journal-title":"Pediatr Nephrol"},{"key":"636_CR32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/01.RES.86.2.139","volume":"86","author":"E Napoleone","year":"2000","unstructured":"Napoleone E, Di Santo A, Camera M, Tremoli E, Lorenzet R (2000) Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes. Circ Res 86:139\u2013143","journal-title":"Circ Res"},{"key":"636_CR33","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0735-1097(99)00318-6","volume":"34","author":"H Soejima","year":"1999","unstructured":"Soejima H, Ogawa H, Yasue H, Kaikita K, Takazoe K, Nishiyama K, Misumi K, Miyamoto S, Yoshimura M, Kugiyama K, Nakamura S, Tsuji I (1999) Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction. J Am Coll Cardiol 34:983\u2013988","journal-title":"J Am Coll Cardiol"},{"key":"636_CR34","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1592\/phco.23.10.1141.32763","volume":"23","author":"JP Tsikouris","year":"2003","unstructured":"Tsikouris JP, Cox CD (2003) Pharmacologic blockade of the renin-angiotensin system: vascular benefits beyond commonly understood pharmacologic actions Pharmacotherapy 23:1141\u20131152","journal-title":"Pharmacotherapy"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-007-0636-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-007-0636-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-007-0636-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T23:09:09Z","timestamp":1588115349000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-007-0636-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,30]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["636"],"URL":"https:\/\/doi.org\/10.1007\/s00467-007-0636-6","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,30]]}}}